This week on Contemporary OB/GYN: July 4 to July 8
A look at what's coming to Contemporary OB/GYN® this week.
Demystifying AVMs
A peer-reviewed article on risk assessment and management of brain arteriovenous malformations in pregnancy.
Beware of “forever chemicals”
A peer-reviewed article about why and how to counsel pregnant and breastfeeding patients about the dangers of exposure to PFAS.
Prenatal exposure to antiseizure medication and autism
Prenatal exposure to the antiseizure medications topiramate and valproate may cause a significantly increased risk of neurodevelopmental disorders in offspring, according to a cohort study in JAMA Neurology.
Contemporary OB/GYN® Volume 67, No 7
Stay tuned this week for the latest issue of Contemporary OB/GYN®.
Buprenorphine use in pregnancy linked to decreased fetal breathing movements
May 18th 2024According to a poster presented at ACOG 2024, use of the synthetic opioid buprenorphine depressed fetal breathing in biophysical profile assessments, but had no significant impact on other factors like amniotic fluid index or fetal tone.
Read More
